In yesterday’s Wall Street session, Zomedica Corp (AMEX:ZOM) shares traded at $0.14, up 2.93% from the previous session.
ZOM stock price is now 7.61% away from the 50-day moving average and -16.62% away from the 200-day moving average. The market capitalization of the company currently stands at $141.11M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $6, Dawson James recently initiated with Buy rating for Zomedica Corp (AMEX: ZOM).
In other news, POWERS JOHNNY D, Director bought 100,000 shares of the company’s stock on Dec 15 ’23. The stock was bought for $16,500 at an average price of $0.17. Upon completion of the transaction, the Director now directly owns 1,950 shares in the company, valued at $273.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 17 ’23, Director POWERS JOHNNY D bought 100,000 shares of the business’s stock. A total of $16,600 was incurred on buying the stock at an average price of $0.17. This leaves the insider owning 1,850,000 shares of the company worth $0.26 million. A total of 1.59% of the company’s stock is owned by insiders.
During the past 12 months, Zomedica Corp has had a low of $0.12 and a high of $0.25. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 17.12, and a quick ratio of 16.57. The fifty day moving average price for ZOM is $0.1337 and a two-hundred day moving average price translates $0.1725 for the stock.
The latest earnings results from Zomedica Corp (AMEX: ZOM) was released for Sep, 2023. According to the Medical Devices Company, earnings per share came in at $0, inline with analysts’ expectations of $0. This compares to -$0.01 EPS in the same period last year. The net profit margin was -62.21% and return on equity was -5.64% for ZOM. The company reported revenue of $6.35 million for the quarter, compared to $4.78 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 32.89 percent. For the current quarter, analysts expect ZOM to generate $7M in revenue.
